Core Laboratories Inc(CLB) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 22.16 | EPS (ttm) | 0.56 | Insider Own | 1.46% | Shs Outstand | 45.9M | Perf Week | -0.24% |
| Market Cap | 0.57B | Forward P/E | 17 | EPS next Y | 61.33% | Insider Trans | 0.75% | Shs Float | 45.2M | Perf Month | 0.4% |
| Enterprise Value | 0.72B | PEG | 1.93 | EPS next Q | 0.15 | Inst Own | 115.38% | Short Float | 9.06% | Perf Quarter | -5.66% |
| Income | 0.03B | P/S | 1.1 | EPS this Y | -39.24% | Inst Trans | -3.68% | Short Ratio | 4.99 | Perf Half Y | -21.38% |
| Sales | 0.52B | P/B | 2.1 | EPS next 5Y | 8.79% | ROA | 4.46% | Short Interest | 4.10M | Perf YTD | -22.02% |
| Book/sh | 5.94 | P/C | 25.22 | EPS past 3/5Y | 15.03% - | ROE | 9.92% | 52W High | -38.61% ($20.36) | Perf Year | -1.34% |
| Cash/sh | 0.5 | P/FCF | 39.31 | Sales past 3/5Y | 2.44% 1.56% | ROIC | 6.22% | 52W Low | 27.68% ($9.79) | Perf 3Y | -51.02% |
| Dividend Est. | $0.04 (0.32%) | EV/EBITDA | 13.29 | EPS Y/Y TTM | -9.4% | Gross Margin | 16.66% | Volatility(W/M) | 4.31% 3.71% | Perf 5Y | -55.07% |
| Dividend TTM | 0.04 | EV/Sales | 1.39 | Sales Y/Y TTM | 0.35% | Oper. Margin | 7.6% | ATR (14) | 0.48 | Perf 10Y | -88.66% |
| Dividend Ex-Date | 2026/8/10 | Quick Ratio | 1.55 | EPS Q/Q | -43.46% | Profit Margin | 5.1% | RSI (14) | 56.66 | Recom | 2.75 |
| Dividend Gr. 3/5Y | - -32.24% | Current Ratio | 2.12 | Sales Q/Q | -4.26% | SMA20 | 0.68% ($12.42) | Beta | 1.11 | Target Price | $15.17 |
| Payout | 6.26% | Debt/Eq | 0.61 | Earnings | 2026/7/29 | SMA50 | 6.31% ($11.76) | Rel Volume | 0.4 | Prev Close | $12.53 |
| Employees | 3300 | LT Debt/Eq | 0.56 | EPS/Sales Surpr. | 26.58% -1.31% | SMA200 | -16.55% ($14.98) | Avg Volume(3M) | 0.82M | Price | $12.5 |
| IPO | 1995/9/21 | Option/Short | Yes/Yes | Trades | 3431 | Volume | 328,922 | Change | -0.24% |
Company
CLB is a Energy sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🛢️ Core Laboratories (ticker: CLB) is an oilfield services company that provides reservoir description and production enhancement technology services to the oil and gas industry. It analyzes rock and fluid samples collected during crude oil and natural gas drilling to help drillers improve reservoir performance and maximize production. The company operates from numerous locations worldwide and specializes in technology-intensive analytical services.
Over the past 1 year, roughly in the middle
39% below its 1-year high.
CLB makes money exceptionally well
7.6% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by -39.2% this year.
Tap to view numbers
The price looks about right
Trading at 22.2 times earnings.
Tap to view numbers
Results came in about as expected
Mixed beats and misses
Tap to view numbers
The outlook is positive
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Would have changed by -51.0% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 0.32% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 115.4%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #4 in the industry
Based on market cap of $574M.
FAQ
What kind of company is CLB?
CLB belongs to the Energy sector and operates in the Oil & Gas Equipment & Services industry.
What is the market cap of CLB?
The market cap of CLB is approximately $574M, ranking 3,117 within its sector.
Does CLB pay dividends?
CLB has a dividend yield of approximately 0.32%, with an annual dividend of $0.04.
What is the P/E ratio of CLB?
CLB has a P/E ratio of approximately 22.2x, which can be used to assess its valuation relative to the Energy sector average.
What is the 52-week high and low for CLB?
CLB has recorded a 52-week high of $20.36 and a low of $9.79.